Mutations in EGFR, KRAS, and BRAF are common in non-small cell lung cancer (NSCLC), while ALK, ROS1, and RET rearrangements define distinct molecular subtypes [15]. This evidence concerns the gene BRAF and non-small cell lung carcinoma.